1. Home
  2. STVN vs EDU Comparison

STVN vs EDU Comparison

Compare STVN & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • EDU
  • Stock Information
  • Founded
  • STVN 1949
  • EDU 1993
  • Country
  • STVN Italy
  • EDU China
  • Employees
  • STVN N/A
  • EDU N/A
  • Industry
  • STVN Containers/Packaging
  • EDU Other Consumer Services
  • Sector
  • STVN Consumer Discretionary
  • EDU Real Estate
  • Exchange
  • STVN Nasdaq
  • EDU Nasdaq
  • Market Cap
  • STVN 6.6B
  • EDU 7.3B
  • IPO Year
  • STVN 2021
  • EDU 2006
  • Fundamental
  • Price
  • STVN $23.20
  • EDU $46.64
  • Analyst Decision
  • STVN Buy
  • EDU Hold
  • Analyst Count
  • STVN 6
  • EDU 4
  • Target Price
  • STVN $25.08
  • EDU $48.50
  • AVG Volume (30 Days)
  • STVN 294.9K
  • EDU 864.5K
  • Earning Date
  • STVN 08-05-2025
  • EDU 07-30-2025
  • Dividend Yield
  • STVN 0.26%
  • EDU 1.24%
  • EPS Growth
  • STVN N/A
  • EDU 27.46
  • EPS
  • STVN 0.50
  • EDU 2.29
  • Revenue
  • STVN $1,215,562,040.00
  • EDU $4,793,786,000.00
  • Revenue This Year
  • STVN $8.69
  • EDU $13.57
  • Revenue Next Year
  • STVN $10.67
  • EDU $13.00
  • P/E Ratio
  • STVN $48.09
  • EDU $20.49
  • Revenue Growth
  • STVN 3.81
  • EDU 18.73
  • 52 Week Low
  • STVN $16.56
  • EDU $40.66
  • 52 Week High
  • STVN $25.75
  • EDU $87.26
  • Technical
  • Relative Strength Index (RSI)
  • STVN 49.43
  • EDU 46.54
  • Support Level
  • STVN $22.70
  • EDU $46.24
  • Resistance Level
  • STVN $24.80
  • EDU $48.04
  • Average True Range (ATR)
  • STVN 1.09
  • EDU 1.05
  • MACD
  • STVN -0.03
  • EDU -0.06
  • Stochastic Oscillator
  • STVN 50.79
  • EDU 40.26

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About EDU New Oriental Education & Technology Group Inc.

New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

Share on Social Networks: